ArticleFunctional & integrative genomics2026
Genomic exploration of Serratia rubidaea MJ24 uncovers diverse biosynthetic capacity and agricultural relevance.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The genus Serratia encompasses metabolically versatile and ecologically significant bacteria, yet the genomic and biosynthetic potential of Serratia rubidaea remains largely unexplored compared to the well-studied S. marcescens. In this study, we present a comprehensive genomic characterization of S. rubidaea MJ24, a pigment-producing strain isolated from the Western Ghats, India. The 4.98 Mb genome (GC content: 59.22%) assembled into 25 contigs exhibits 100% completeness and minimal contamination, indicating high assembly quality. Functional annotation revealed 4,692 (4,569 Protein coding) coding sequences enriched in metabolism-related genes, stress tolerance, and secondary metabolite biosynthesis. Genome mining using AntiSMASH identified twelve biosynthetic gene clusters (BGCs), including those responsible for prodigiosin, pyrrolnitrin, aerobactin, and enterobactin biosynthesis, which were experimentally confirmed by LC-QTOF-MS, along with two of moderate similarity and six other BGCs of unassigned function. Phylogenomic and ANI analyses confirmed its placement within the S. rubidaea clade. The strain harbors an array of plant growth-promoting traits, including phytohormone biosynthesis (IAA, cytokinins), siderophore production, stress control, and heavy metal resistance genes. Together, the BGCs and plant growth-promoting traits underscore its potential as a biocontrol agent and biofertilizer. Collectively, the findings reveal S. rubidaea MJ24 as a metabolically versatile bacterium with a rich secondary metabolite repertoire and significant agricultural and biotechnological promise.
Indexed as
Identifiers
42584495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.